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Seventually additional stent implantation in SB ostium) while leading to ischemic
compromise. Nevertheless, there is little data using FD-OCT imaging to better
understand the relationship between underlying plaque and acute stent-vessel inter-
actions in this setting.We aim to evaluate, by means frequency-domain optical
coherence tomography (FD-OCT), the impact of main branch (MB) calciﬁed plaques
on side branch (SB) occlusion after MB stent implantation in coronary bifurcations.
Methods: We evaluated 78 patients with native de novo coronary bifurcation lesions
with SB deserving wire protection (side-branch length greater than 50mm) who
underwent MB FD-OCT before stent implantation. FD-OCT assessments were per-
formed pre-PCI to evaluate the plaque type calcium and non-calcium (ﬁbrous and
lipid) of main branch. SB occlusion was deﬁned as % diameter stenosis greater than
75% of SB ostium by angiogram after MB stent implantation.
Results: Occlusion of SB occurred in 43.6%- while 18 patients required balloon
angioplasty for SB occlusion. In multivariable analysis, true bifurcation (odds ratio
[OR]: 3.70; 95% conﬁdence interval [CI]: 1.13 to 12.58; p ¼ 0.030) and calciﬁed
plaque determined by FD-OCT assessments (OR: 17.11; 95% CI: 4.97 to 58.96; p <
0.001) were independent predictors of SB occlusion.
Conclusions: Calciﬁed plaque demonstrated by FD-OCT assessments as well as true
bifurcations were identiﬁed as independent predictors of SB occlusion after MB stent
implantation.
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Background: Everolimus-eluting bioabsorbable vascular scaffold (BVS) is a new
promising therapeutic technology for the treatment of coronary heart disease.
However, clinical experience with this device is still limited in patients with acute
coronary syndrome and thrombus containing lesions. The purpose of this study is to
analyze the usefulness of the optical coherence tomography (OCT) in the monitori-
zation of these procedures.
Methods: From January 2012 to May 2013, 66 patients with acute coronary syndrome
were treated by BVS implantation. After identiﬁcation of the culprit lesion, a baseline
intravascular ultrasound study (IVUS) was performed. Taking into consideration the
IVUS information, direct stent deployment was carried out in 44 patients (67%). After
the BVS implantation, an OCT catheter was advanced distal to the area of interest over
a conventional coronary guide-wire. Several pullbacks were performed to obtain an
optimal visualization of the treated segment.
Results: The mean age was 559 years, 25 (38%) patients had ST elevation and the
remaining 41 had ACS without ST elevation. After treatment, the percentage of
stenosis changed from 8115% to 66%. According with the angiographic criteria,
the procedure was successful in all 66 patients. However, immediately after the BVS
deployment the OCT showed the following negative ﬁndings: 1) Proximal struts non
apposition 13 (20%). 2) Distal struts non apposition 3 (4%). 3) Prolapse of the plaque
or thrombus into the BVS 24 (36%). 4) Proximal edge dissection (non-detected by
angiography) 8 (12%). 5) Distal edge dissection (non-detected by angiography) 10
(15%). 6) Severe BVS under-expansion 4 (6%). 7) Main vessel BVS deformation after
side branch dilation 4 (out of 10 treated bifurcation lesions). According with these
ﬁndings the operator modiﬁed the procedural strategy in 36 patients (54%): 1) Post-
dilation of the BVS with a new balloon in 28 (42%). 2) Kissing balloon or sequential
dilation (side-main-side) in 4 bifurcation lesions. There were no in-hospital major
complications.
Conclusions: Angiography has limitations in the assessment of the immediate results
after BVS treatment of coronary lesions. However, OCT is an useful adjunctive tool
during the monitorization of this procedure in patients with acute coronary syndromes.
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Background: Atherosclerosis is a systemic inﬂammatory disease involving multiple
arterial beds. Despite differences in the carotid and coronary vasculature, both
vascular distributions are believed to share common pathway in disease progression. It
is not known whether the atherosclerotic plaque composition is associated with stent
restenosis and atherosclerosis progression.
Methods: In Latvian Center of Cardiology patients for previous indications under-
went coronary and carotid angiography. Patients with concomitant coronary andB176 JACC Vol 62/18/Suppl B j October 27–Novecarotid artery disease deﬁned as 50 % stenosis were included in single-center,
prospective study. All patients were scheduled for carotid and/or coronary artery
stenting and prior to intervention IVUS-VH (Eagle Eye; Volcano Therapeutics Inc;
CA, USA) imaging of coronary and carotid plaque were done. Angiography and
IVUS-VH follow-up was scheduled after 16 month.
Results: 100 consecutive patients (60% men), mean age 69.68.4 years, were
enrolled. 78.0% of patients (n¼78) underwent carotid stenting and 36.0% (n¼36) had
PCI. For 75 patients angiographic and IVUS-VH follow-up was done (mean 489 days,
95% CI 507.0 - 631.8). Carotid restenosis rate was 1.8% (n¼1). 3 of 17 patients
(17.6%) had plaque progression and consequent carotid stenting. Coronary restenosis
rate was 25.8% (8 of 31 patients). We found no difference in unstented carotid plaque
tissue composition by IVUS-VH at baseline between progressive (n¼3) and
nonprogressive (n¼14) carotid plaques (ﬁbrotic tissue 56.78.4% vs 57.37.4%,
p¼0.898, ﬁbrolipids 15.07.5% vs 18.79.3%, p¼0.531, calcium 5.73.5% vs
5.84.0%, p¼0.959, necrotic core 22.312.9% vs 18.49.7%, p¼0.548). Similarly,
no association with IVUS-VH characteristics of culprit lesion at baseline was found
between coronary restenosis (n¼8) and no-restenosis (n¼23) group.
Conclusions: Atherosclerotic plaque tissue characteristics by IVUS-VH were not
associated with carotid plaque progression and frequency of restenosis in coronary
arteries in these series. Restenosis rate in carotid arteries is low in comparison with
coronary arteries regardless of the stenosis morphological differences.
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Background: The COLOR Registry is a prospective, multicenter observational study
of real-world pts undergoing percutaneous coronary intervention who also had
intracoronary imaging using near infrared spectroscopy (NIRS).
Methods: We investigated the relationship between the extent of lipid rich plaque
(LRP) assessed by pre-intervention NIRS at the time of drug-eluting stent (DES)
implantation and subsequent DES failure (restenosis or thrombosis). Raw spectro-
scopic information was transformed into a probability of LRP; pixels with a proba-
bility of LRP >0.6 were divided by all viable pixels to generate the lipid-core burden
index (LCBI). Case-control matching was performed with respect to age, gender,
diabetes, baseline symptoms, stent type, stent length, and time to event.
Results: Eleven pts who developed DES failure [10 restenosis (1 proximal edge, 9 in-
stent) and 1 subacute stent thrombosis] at a median of 363 days (range 8-598 days)
post-implantation and NIRS study were compared to 27 matched cases without stent
failure. Baseline characteristics were well-matched between the groups (Table).
Although stent length and ﬁnal diameter stenosis were similar in both groups, stented
segment LCBI was signiﬁcantly greater in the stent failure group than in the control
group with no different in the adjacent reference segments. Importantly, DES failure
was not seen in the setting of a maxLCBI4mm <100.mber 1, 2013 j TCT Abstracts/POSTER/Intravascular Imaging and PCI
Pat. with
bioabsorbable
polymer DES
n = 13
Pat. with durable
polymer DES
n = 37
Total
n = 50
Age at 1y FUP 56,4
(IQR: 51,5 - 60,0)
61,6
(IQR: 54,2 - 70,0)
60,2
(IQR: 53,0 - 66,0)
Gender (m/f) 10 / 3 29 / 8 39 / 11
FUP period 364,2 (17,3) 363,3 (18,4) 363,5 (18,0)
DES (EES/ZES/
BES)
n ¼ 17 (-/-/17) n ¼ 43 (25/18/-) n ¼ 60
Stent length 22,94 (7,25) 23,3 (8,07) 23,2 (7,79)
Stent diameter 2,99 (0,38) 2,97 (0,4) 2,97 (0,39)
Struts total 1y* 3.291
(193,6 80,1)
12.385
(288 168,9)
15.676
(261,3 154,6)
DES with LASM 0 10 10
DES without LASM 17 33 50
Patients and stents characteristics, signiﬁcant difference between groups at occurance of
LASM (p¼0,0492)
* struts counted in every 4th frame
Stent Failure
(N=11)
Non-Stent Failure
(N=27) p value
Baseline
characteristics
Age, years 652 622 0.22
Male, % (n) 91 (10) 100 (27) 0.30
Diabetes, % (n) 55 (6) 59 (16) 0.79
Acute coronary
syndrome, % (n)
45 (5) 41 (11) 0.79
NIRS ﬁndings
before stenting
LCBI in the
stented segment
160112 9870 0.042
MaxLCBI4mm * 503335 353242 0.12
LCBI in the
proximal reference
5981 5279 0.83
LCBI in the distal
reference
4557 2784 0.55
MaxLCBI4mm
<100, % (n)
0 (0) 19 (5) 0.30
Final QCA results
at index procedure
Total stent
length, mm
30.522.0 32.015.1 0.83
Minimal lumen
diameter, mm
2.20.5 2.20.4 0.94
Reference vessel
diameter, mm
2.80.3 3.00.3 0.22
Percent
diameter stenosis,
%
23.811.2 20.311.4 0.38
* MaxLCBI4mm ¼ maximum LCBI in any 4mm-long segment
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SConclusions: Pre-intervention NIRS revealed more LRP in lesions that subsequently
developed DES failure compared to DES-treated lesions without stent failure. Pre-
intervention NIRS evaluation may help to identify lesions at high risk of DES
thrombosis or restenosis.
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Background: Uncovered stent struts of drug-eluting stents (DES) are associated with
late stent thrombosis. Early and late malapposition of stent struts may be the major
mechanisms for uncovered struts. Durable polymer may contribute to late acquired
stent malapposition. Optical coherence tomography (OCT) enables the evaluation of
stent strut apossition due to high-resoluted intravascular images.
Methods: This study examines malapposition of DES with and without bioabsorbable
polymer in patients who underwent elective percutaneous coronary intervention (PCI).
Methods: Fifty patients treated with 60 DESs (25 Everolimus-eluting stents [EES], 18
Zotarolimus- eluting stents [ZES], 17 Biolimus-eluting stents [BES]) underwent OCT
directly after implantation and after 12 months.
Results: Postintervention acute stent malapposition (ASM) occurred in 30 stents
(50%). Of these, malappositions in 21 stents resolved completely (70%), whereas 9
malappositions persisted after one year (30%, malapposed segements in 6 stents
resolved partly whereas malappositions in 3 stents persisted completely). At this time-
point, a total 15 stents (25%) with late stent malappositions were detected due to late
acquired stent malapposition (LASM) in 10 stents (17%). The occurance of LASM
was signiﬁcantly higher in stents without bioabsorbable polymer (10 in EES and ZES
- 100%) than in stents with bioabsorbable polymer (0 BES - 0%; p¼0,0492).
Conclusions: The use of bioabsorbable polymer may reduce late acquired stent
malapposition.JACC Vol 62/18/Suppl B j October 27–November 1, 2013 j TCT AbstrTCT-585
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Background: Due to the lack of imaging modalities with a resolution down to the
magnitude of a few cells, the direct inﬂuence of endothelial progenitor cells (EPC) on
re-endothelialization of drug-eluting stents has not been established in patients. Here,
we assessed the potential of different subsets of circulating endothelial cells and EPC
to inﬂuence stent re-endothelialization using second generation optical coherence
tomography (OCT).
Methods: In 40 patients, everolimus-eluting stents were assessed by optical frequency
density intensity OCT 5-7 months after stent implantation. Stent strut coverage as well
as neointima formation was derived from detailed analysis of OCT data. Circulating
endothelial cells (CEC; CD31+CD45-) and different subsets of EPC (e.g.
CD34+KDR+, CD34+KDR+CD45dim, CD3+CD31+, CD133+) were analyzed by
ﬂow cytometry. Statistical analysis was performed by mixed linear effect models
integrating OCT and ﬂow cytometry data as well as multiple clinical variables.
Results: Stent strut coverage and frequency of different cell populations were highly
comparable with previous OCT and ﬂow cytometry data. On univariate and in mixed
linear effect models, no association between EPC counts and re-endothelialization was
detected. For CD31+CD45- counts, an inverse relationship with re-endothelialization
was identiﬁed by mixed linear effect model building adjusting for age, female sex,
diabetes mellitus, NYHA and CCS stadium, serum triglycerides, glucose and creati-
nine (beta ¼ -8.375, p¼0.011).
Conclusions: Circulating CEC were associated with low stent strut coverage. There
was no signiﬁcant association between circulating EPC and healing after drug-eluting
stent implantation. These data suggest that endothelial damage quantitated by CEC
may represent a more important mediator of late stent re-endothelialization than
endovascular repair assessed by EPC.acts/POSTER/Intravascular Imaging and PCI B177
